Global Nucleic Acid Isolation and Purification (NAIP) Industry Report 2018 with $5.3 Billion DROC Analysis - ResearchAndMarkets.com

May 16, 2018

DUBLIN--(BUSINESS WIRE)--May 16, 2018--The “Global Nucleic Acid Isolation and Purification (NAIP) Market - Segmented by Technology, Application, Product, End-Users and Geography - Growth, Trends and Forecasts (2018 - 2023)” report has been added to ResearchAndMarkets.com’s offering.

The global nucleic acid isolation and purification (NAIP) market is estimated to reach approximately USD 5,300 million by 2023, at a CAGR of about 9% during the forecast period.

This market is segmented based on technology, product, application, end user, and geography. In the segmentation based on technology, column-based purification has the largest market share, however, magnetic bead-based purification is expected to witness the highest CAGR.

Biotech and Pharma companies have a growing demand for pure nucleic acids. Pure nucleic acid is finding applications in emerging fields, like genetic engineering, molecular diagnosis, forensics, and research related to life sciences. Consequently, the governments have stepped up funding for R&D projects. The pharma sector has stepped up investments in products requiring NAIP Instruments, as NAIP technologies are becoming more prevalent now. Rise in automation has also stepped up NAIP applications.

The availability of automation technology in emerging economies is very low. Automation technology is a major reason for rising applicability of NAIP technology. Low automation presents a problem in harnessing the full potential of NAIP technology. Companies would need to work out ways to increase the availability of automation technology in the developing regions.

As the penetration of automation and NAIP technology is low in emerging economies, consequently the cost of automated instruments is also very high (higher than the base cost in developed countries). These hurdles of pricing and technology penetration are potential barriers for the market’s growth.

Companies Mentioned

Agilent Technologies Bio-Rad Laboratories Danaher Corporation GE Healthcare Roche Applied Sciences Sigma Aldrich Life Technologies Thermo Fisher Scientific Takara Bio Inc.

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

10. Future of the Market

For more information about this report visit https://www.researchandmarkets.com/research/666nbc/global_nucleic?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180516005639/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Biotechnology



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 05/16/2018 07:00 AM/DISC: 05/16/2018 07:01 AM


Update hourly